Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study.

Blomström-Lundqvist C, Marrouche N, Connolly S, Corp Dit Genti V, Wieloch M, Koren A, Hohnloser SH

Open source

DOI
10.1002/clc.23463
Published
2020 Dec
Container
Clinical cardiology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/clc.23463,
  title = {Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study.},
  author = {Blomström-Lundqvist C and Marrouche N and Connolly S and Corp Dit Genti V and Wieloch M and Koren A and Hohnloser SH},
  year = {2020},
  journal = {Clinical cardiology},
  doi = {10.1002/clc.23463},
  url = {https://doi.org/10.1002/clc.23463}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study.
AU  - Blomström-Lundqvist C
AU  - Marrouche N
AU  - Connolly S
AU  - Corp Dit Genti V
AU  - Wieloch M
AU  - Koren A
AU  - Hohnloser SH
PY  - 2020
JO  - Clinical cardiology
DO  - 10.1002/clc.23463
UR  - https://doi.org/10.1002/clc.23463
ER  - 

APA

C, B., N, M., S, C., V, C. D. G., M, W., A, K., & SH, H. (2020). Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study.. Clinical cardiology. https://doi.org/10.1002/clc.23463

Source records